Aethlon Medical, based in San Diego with 14 employees, develops diagnostic and therapeutic products, including the FDA-designated Hemopurifier for treating advanced cancer and life-threatening viruses.
Aethlon Medical (AEMD) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Aethlon Medical's actual EPS was -$1.04, beating the estimate of -$1.74 per share, resulting in a 40.26% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
